Innovative Value-Based Care Partnership Cuts Costs for Cancer Treatment Through Weight-Based Dosing #USA #Nashville #KEYTRUDA #Thyme_Care #Texas_Oncology

Ich habe nach den jüngsten US-News mit #Formycon-CEO Stefan Glombitza ausführlicher über das #Keytruda-Biosimilar #FYB206 gesprochen, das einen Milliardenmarkt erobern soll.

Formycon: „Wir gehören zur Spitzengruppe“ - Interview www.4investors.de/nachrichten/...

Zydus and Formycon's FYB206: Keytruda® Biosimilar Review by USFDA #United_States #Ahmedabad #KEYTRUDA #Formycon #Zydus

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more news.. statnews.com/pharmalot/20... #pharma #biotech #Trump #tariffs #Merck #Keytruda #patent #abortion #peptides #Roche #China

#MSD has been rocked by a #courtjudgment ordering it to stop manufacturing and selling its #subcutaneous formulation of cancer immunotherapy #Keytruda in eight #Europeanmarkets.

pharmaphorum.com/news/msd-ord...

Halozyme Secures Key Legal Victory Against Merck's Keytruda in Europe #United_States #San_Diego #Halozyme #Patent #KEYTRUDA

#Keytruda is a type of #immunotherapy called an immune checkpoint inhibitor. It may be prescribed for some people with triple-negative breast cancer, as well as some metastatic or inoperable breast cancers with specific biomarkers, including MSI-H, dMMR, or TMB-H.

Read more: https://bit.ly/4ipejwL